agilon health, inc. (NYSE:AGL) Shares Bought by Signaturefd LLC

Signaturefd LLC lifted its position in shares of agilon health, inc. (NYSE:AGL) by 166.2% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 11,848 shares of the company’s stock after acquiring an additional 7,398 shares during the quarter. Signaturefd LLC’s holdings in agilon health were worth $77,000 at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. J.Safra Asset Management Corp raised its position in agilon health by 626.1% in the second quarter. J.Safra Asset Management Corp now owns 4,204 shares of the company’s stock worth $27,000 after acquiring an additional 3,625 shares in the last quarter. Quest Partners LLC purchased a new position in shares of agilon health in the 4th quarter valued at about $45,000. Neo Ivy Capital Management acquired a new stake in shares of agilon health in the fourth quarter valued at about $47,000. CWM LLC lifted its stake in shares of agilon health by 406.5% in the second quarter. CWM LLC now owns 9,081 shares of the company’s stock valued at $59,000 after purchasing an additional 7,288 shares during the period. Finally, Nisa Investment Advisors LLC purchased a new stake in agilon health during the second quarter worth about $60,000.

Analyst Ratings Changes

A number of research analysts have issued reports on the stock. Baird R W raised shares of agilon health to a “hold” rating in a report on Thursday, May 30th. Evercore ISI lifted their price objective on agilon health from $5.50 to $7.00 and gave the stock an “in-line” rating in a report on Tuesday, July 9th. Robert W. Baird began coverage on agilon health in a report on Thursday, May 30th. They issued a “neutral” rating and a $6.00 target price on the stock. Royal Bank of Canada reaffirmed an “outperform” rating and set a $8.00 price target on shares of agilon health in a research note on Wednesday, August 7th. Finally, Deutsche Bank Aktiengesellschaft decreased their price objective on shares of agilon health from $5.00 to $4.00 and set a “hold” rating on the stock in a research report on Friday, August 9th. One analyst has rated the stock with a sell rating, fourteen have given a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat, the company has an average rating of “Hold” and an average target price of $8.57.

agilon health Stock Performance

Shares of AGL opened at $4.17 on Thursday. agilon health, inc. has a 1 year low of $3.74 and a 1 year high of $20.37. The company’s 50 day simple moving average is $5.76 and its 200 day simple moving average is $5.75. The company has a market capitalization of $1.71 billion, a price-to-earnings ratio of -5.96 and a beta of 0.60. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.36 and a current ratio of 1.36.

agilon health (NYSE:AGL) last announced its quarterly earnings data on Tuesday, August 6th. The company reported ($0.07) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.07). The company had revenue of $1.48 billion during the quarter, compared to analysts’ expectations of $1.56 billion. agilon health had a negative net margin of 5.57% and a negative return on equity of 29.91%. The business’s quarterly revenue was up 38.7% compared to the same quarter last year. During the same period in the previous year, the company earned ($0.04) EPS. On average, sell-side analysts predict that agilon health, inc. will post -0.35 EPS for the current year.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.